Home
Clinical Resources Search
PQI: Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Download PQI pdf

Last Updated: December 22, 2023

By: Tammy McClellan, PharmD

About this PQI

The purpose of this PQI is to assess the individualized characteristics of the Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) patient and important screening measures in order to achieve optimal pharmacological therapy.

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Patient Screening for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Cardiovascular Risk associated with Androgen Deprivation Therapy (ADT) in Prostate Cancer

PQI: Administration of Subcutaneous Isatuximab-irfc (SARCLISA ESCENA) via the CirCLIQ On-Body Delivery System

PQI: Teclistamab-cqyv (Tecvayli) in Combination with Daratumumab and Hyaluronidase-fihj (Darzalex Faspro) for Relapsed Multiple Myeloma

PQI: Tafasitamab-cxix (Monjuvi) for Relapsed/Refractory Follicular Lymphoma

PQI in Action: Inavolisib (Itovebi) Patient Management

PQI in Action: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI in Action: Capivasertib (Truqap) Patient Management

PQI in Action: Sutimlimab-jome (Enjaymo) for the Management of Hemolysis in Cold Agglutinin Disease (CAD)

S11 E6: Finding the Heart of Oncology

S11 E7: Your Health Story in One Place

S11 E8: The Future of Oncology

S11 E5: Keep Marching On: Changing the Story of Pancreatic Cancer

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bispecific (T-Cell Engager)

Treatment Support Kit: Zanidatamab-hrii

Treatment Support Kit: Avutometinib and Defactinib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Acalabrutinib

Chlorambucil Taken by Mouth

Chlorambucil and Obinutuzumab

Fludarabine

Cyclophosphamide Given by Infusion

S7 Ep 8: Sickle Cell Disease Insights

Tocilizumab (Actemra)

Pertuzumab (Perjeta), Paclitaxel (Taxol), Carboplatin, and Trastuzumab (Herceptin) (P-TCH)

Camizestrant (Etcamah)

Brentuximab Vedotin and CHP (Cyclophosphamide, Doxorubicin, Prednisone)